Breast Parenchymal Enhancement as a Predictor of Efficacy for Endocrine Therapy

HomeRadiologyVol. 307, No. 4 PreviousNext Reviews and CommentaryEditorialBreast Parenchymal Enhancement as a Predictor of Efficacy for Endocrine TherapyMaya Honda , Mami IimaMaya Honda , Mami IimaAuthor AffiliationsFrom the Department of Diagnostic Radiology, Kansai Electric Power Hospital, 2-1-7 Fukushima, Fukushima-ku, Osaka 553-0003, Japan (M.H.); Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan (M.H., M.I.); and Institute for Advancement of Clinical and Translational Science, Kyoto University Hospital, Kyoto, Japan (M.I.).Address correspondence to M.H. (email: [email protected]).Maya Honda Mami IimaPublished Online:Mar 28 2023https://doi.org/10.1148/radiol.230350MoreSectionsFull textPDF ToolsImage ViewerAdd to favoritesCiteTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinked In References1. Giaquinto AN, Sung H, Miller KD, et al. Breast Cancer Statistics, 2022. CA Cancer J Clin 2022;72(6):524–541. Crossref, Medline, Google Scholar2. Cucciniello L, Gerratana L, Del Mastro L, Puglisi F. Tailoring adjuvant endocrine therapy in early breast cancer: When, how, and how long? Cancer Treat Rev 2022;110:102445. Crossref, Medline, Google Scholar3. Ragusi MAA, van der Velden BHM, van Maaren MC, et al. Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA. Breast Cancer Res Treat 2022;193(1):161–173. Crossref, Medline, Google Scholar4. Onishi N, Li W, Newitt DC, et al. Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology 2021;301(2):295–308. Link, Google Scholar5. Kim SY, Cho N, Choi Y, et al. Factors Affecting Pathologic Complete Response Following Neoadjuvant Chemotherapy in Breast Cancer: Development and Validation of a Predictive Nomogram. Radiology 2021;299(2):290–300. Link, Google Scholar6. Lee SH, Jang MJ, Yoen H, et al. Background Parenchymal Enhancement at Postoperative Surveillance Breast MRI: Association with Future Second Breast Cancer Risk. Radiology 2023;306(1):90–99. Link, Google Scholar7. Ragusi MAA, van der Velden BHM, Meeuwis C, et al. Long-term Survival in Breast Cancer Patients is associated with Contralateral Parenchymal Enhancement at MRI: outcomes of the SELECT-study. Radiology 2023;307(4):e221922. Link, Google Scholar8. D'Orsi CJ, Sickles EA, Mendelson EB, Morris EA, et al. ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. Reston, VA: American College of Radiology, 2013. Google Scholar9. Ragusi MAA, Loo CE, van der Velden BHM, et al. Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index. Eur Radiol 2020;30(12):6740–6748. Crossref, Medline, Google Scholar10. van der Velden BHM, Dmitriev I, Loo CE, Pijnappel RM, Gilhuijs KGA. Association between Parenchymal Enhancement of the Contralateral Breast in Dynamic Contrast-enhanced MR Imaging and Outcome of Patients with Unilateral Invasive Breast Cancer. Radiology 2015;276(3):675–685. Link, Google ScholarArticle HistoryReceived: Feb 11 2023Revision requested: Feb 20 2023Revision received: Feb 22 2023Accepted: Feb 27 2023Published online: Mar 28 2023 FiguresReferencesRelatedDetailsAccompanying This ArticleLong-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT StudyMar 28 2023RadiologyRecommended Articles Multiparametric MRI and Radiomics to Predict HER2-Low Cancer: The Potential Therapeutic ImpactRadiology2023Volume: 308Issue: 2Preoperative Breast MRI Is Not a Significant Prognostic Factor of Recurrence-Free Survival and Overall Survival in Young WomenRadiology2023Volume: 307Issue: 4Long-term Survival in Breast Cancer Patients Is Associated with Contralateral Parenchymal Enhancement at MRI: Outcomes of the SELECT StudyRadiology2023Volume: 307Issue: 4MRI to Detect Contralateral Breast Cancer in Patients with Newly Diagnosed Breast Cancer: An Increase in Overall Survival to Be ConfirmedRadiology2022Volume: 304Issue: 2pp. 308-309Contralateral Breast Screening with Preoperative MRI: Long-Term Outcomes for Newly Diagnosed Breast CancerRadiology2022Volume: 304Issue: 2pp. 297-307See More RSNA Education Exhibits Theranostic Approach In Breast CancerDigital Posters2021The Utility Of 18F-FES PET In Breast Cancer.Digital Posters2021Staging Breast Cancer: A Case Based ReviewDigital Posters2022 RSNA Case Collection Occult Breast CancerRSNA Case Collection2022Multifocal breast cancerRSNA Case Collection2020Inflammatory breast cancerRSNA Case Collection2020 Vol. 307, No. 4 Metrics Altmetric Score PDF download